Mesa Laboratories Inc
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 18.4% | 21.6% | 21.9% | 17.9% | 9.1% | 29.3% | 20.4% | 3.2% | 13.5% | 28.8% | 21.9% | 24.5% | 22.3% | |
| 15.2% | 16.9% | 10.7% | 9.4% | 10.5% | 8.7% | 12.1% | 10.0% | 9.6% | 8.8% | -27.5% | 9.4% | -0.1% | |
| 6.0% | 5.6% | 4.7% | 5.0% | 6.6% | 5.2% | 5.1% | 6.5% | 6.3% | 5.2% | -17.4% | 3.9% | -0.6% | |
| -2.6% | -0.2% | 14.5% | -0.6% | 0.6% | 5.7% | 15.6% | -13.4% | -9.0% | 15.3% | 6.2% | -0.1% | 3.4% | |
| 1.2% | 2.1% | 0.9% | 1.5% | 3.1% | 1.3% | 1.6% | 1.7% | 1.8% | 1.1% | 4.4% | 0.9% | 2.1% | |
| -1.2% | -151.2% | 0.7% | -1.5% | -3.1% | -1.3% | -1.6% | -1.7% | -1.8% | -1.1% | -0.7% | -0.9% | -1.1% | |
| 1.6% | 1.6% | 1.5% | 1.5% | 1.5% | 1.4% | 1.4% | 1.5% | 1.5% | 1.4% | 1.4% | 1.5% | 1.4% | |
| 0.0% | 0.0% | 1.2% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -12.3% | -15.0% | -28.9% | 5.1% | -10.6% | -13.3% | -23.0% | -14.4% | -15.4% | |
| -10.5% | 113.8% | -22.0% | -15.7% | -14.9% | -16.9% | -26.1% | -14.2% | -13.0% | -15.0% | -24.7% | -17.5% | -17.6% | |
| 6.1% | -13.8% | 0.0% | 0.4% | -7.1% | 10.5% | -5.9% | -10.1% | -1.4% | 13.1% | -3.2% | 6.3% | 3.8% | |
| 17.2% | 19.5% | 21.0% | 16.4% | 6.0% | 28.0% | 18.8% | 1.5% | 11.7% | 27.7% | 26.4% | 23.6% | 22.5% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.